Literature DB >> 31171307

Imaging in axial spondyloarthritis: Changing concepts and thresholds.

Ulrich Weber1, Xenofon Baraliakos2.   

Abstract

Imaging is key to recognition of axial spondyloarthritis (SpA) because clinical and laboratory examinations have limited diagnostic utility. Only MRI can capture both inflammation and bone remodeling by simultaneous depiction of active and structural lesions and their anatomic location. Bone marrow edema of limited extent on the sacroiliac joint (SIJ) MRI is often nonspecific and should be interpreted along with the clinical context. Contextual interpretation of the SIJ lesion signature viewed simultaneously on fluid- and fat-sensitive MRI sequences enhances confidence in the recognition of disease. A critical re-appraisal of using pelvic radiographs in clinically suspected early spondyloarthritis is warranted because of substantial limitations. In health care settings with low threshold access to advanced imaging, MRI is the preferred modality in early SpA. CT has recently advanced spinal outcome research, but substantial radiation exposure in young patients with spondyloarthritis and limited evidence on its relevance in practice do not advocate its use in daily routine.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Bone marrow edema; Classification; Computed tomography; Diagnosis; Magnetic resonance imaging; Radiography; Spondyloarthritis; Structural lesions

Mesh:

Year:  2018        PMID: 31171307     DOI: 10.1016/j.berh.2018.10.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  4 in total

Review 1.  Biomarker development for axial spondyloarthritis.

Authors:  Matthew A Brown; Zhixiu Li; Kim-Anh Lê Cao
Journal:  Nat Rev Rheumatol       Date:  2020-06-30       Impact factor: 20.543

Review 2.  [Imaging in patients with axial spondylarthritis with focus on new bone formation].

Authors:  X Baraliakos; J Braun
Journal:  Z Rheumatol       Date:  2020-02       Impact factor: 1.372

Review 3.  Imaging in Axial Spondyloarthritis: What is Relevant for Diagnosis in Daily Practice?

Authors:  Ulrich Weber; Anne Grethe Jurik; Robert G W Lambert; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

4.  Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).

Authors:  Walter P Maksymowych; Mikkel Østergaard; Robert Landewé; William Barchuk; Ke Liu; Chantal Tasset; Leen Gilles; Thijs Hendrikx; Robin Besuyen; Xenofon Baraliakos
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.